The search for a liquid biopsy for the early detection of pancreatic cancer summons top European experts in this tumor at the CNIO

by CNIO - Centro Nacional de Investigaciones Oncológicas

The main focus of research is on early detection. Europe’s leading researchers in this tumor are working to diagnose pancreatic cancer years before symptoms appear, with a blood test.

Read more

VHIO - led retrospective study evaluates the clinical and genomic features of early-onset pancreatic cancer

by VHIO

“Results from this present study indicate that EOPC patients have unique clinical and molecular characteristics and could derive particular benefit from precision oncology-based approaches,” concl...

Read more

ibs.GRANADA scientists determine that sodium selenite can improve the response to pancreatic cancer treatment

by Instituto de Investigación Biosanitaria - Ibs Granada

Dr. Kevin Doello González from the Virgen de las Nieves University Hospital in Granada and Dr. Raúl Ortiz Quesada from the University of Granada, both members of this group of scientists from ibs.GR...

Read more

A clinical trial shows the safety and potential of an oncolytic virus against advanced pancreatic cancer

by IDIBELL - Institut d’Investigació Biomèdica de Bellvitge

El ensayo clínico en fase 1 liderado por el IDIBELL y el ICO muestra que la administración del virus VCN-01 es viable y una posible nueva herramienta en el tratamiento del cáncer de páncreas avanz...

Read more

Proinflammatory diets may increase pancreatic cancer risk

by Hospital Universitari de Bellvitge

There is evidence on the effects of diet on the risk of developing pancreatic cancer. There may be a link between pro-inflammatory diets and the possibility of developing pancreatic cancer. Although t...

Read more

VHIO is participating prominently in a study that seeks to evaluate the efficacy of a novel combination therapy in advanced pancreatic cancer

by Vall d’Hebron

The biopharmaceutical company Ability Pharmaceuticals, SL today announced the inclusion of the first patients in a phase 2b clinical trial with its novel autophagy-inducer anticancer compound ABTL0812...

Read more

Driving nano-based approaches closer to the clinic: Vall d’Hebron leads pilot study to assess the efficacy of nanoparticles against pancreatic cancer

by Vall d’Hebron

Nano-based drug delivery and anti-cancer therapy have shown promise in recent years as potential novel weaponry in the current arsenal of anti-cancer technologies. Nano-driven therapeutics involves th...

Read more

In celebration of today’s World Day against Pancreatic Cancer: spotlighting VHIO-led discovery

by Vall d’Hebron

​As a notoriously ‘silent’ disease in terms of identifiable symptoms, pancreatic cancer generally manifests itself at late and advanced stages, with only 20% of patients as candidates for curati...

Read more

CNIO and Columbia University co-lead a multidisciplinary project to study pancreatic cancer early detection

by CNIO - Centro Nacional de Investigaciones Oncológicas

The project aims to identify high-risk populations for pancreatic cancer, to include them in screening and early detection interventions so as to try to increase patients' survival rates

Read more

A gene that increases the risk of pancreatic cancer controls inflammation in normal tissue

by CNIO - Centro Nacional de Investigaciones Oncológicas

CNIO researchers discover that healthy cells suppress inflammation unless it is required. This finding suggests new strategies to improve the prevention of pancreatic cancer. The research is published...

Read more

Ability Pharmaceuticals Announces FDA-Orphan Drug Designation for ABTL0812 in Pancreatic Cancer

by Ability Pharma

Ability Pharmaceuticals, a drug development biopharmaceutical company specialized in oncology, announced today that has received orphan-drug designation (ODD) for ABTL0812 from the US Food and Drug Ad...

Read more

Dr. Schwartz Jr participates in a European nanomedicine project for pancreatic cancer

by Vall d’Hebron

The research comes as the results of an earlier European study which showed in animal models the efficacy of a therapeutic nanoconjugate against pancreatic cancer. Based on these results, the research...

Read more
Subscribe to Directory
Write an Article

Recent News

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un estudio de INCLIVA muestra el efecto ...

by INCLIVA

Han desarrollado un estudio para evaluar la correlación entre el teji...

Photos Stream